US Broker Ratings

Aura Biosciences, Inc. (AURA): Biotechnology Stock with 248% Upside Potential Draws Investor Attention

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company based in Boston, Massachusetts, is capturing investor interest with its innovative approach to treating solid tumors. The..

Nyxoah SA (NYXH) Stock Analysis: A Compelling Investment with 108% Potential Upside

Nyxoah SA (NASDAQ: NYXH) presents a fascinating opportunity for investors looking to capitalize on the burgeoning healthcare sector, specifically within the medical instruments and supplies industry...

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a 50% Upside in the Innovative Medical Device Sector

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector with its cutting-edge advancements in medical devices, particularly through its focus on Next Generation Protein..

Chevron Corporation (CVX) Investor Outlook: Assessing Potential Upside Amidst Robust Dividends

Chevron Corporation (NYSE: CVX) stands as a formidable player in the energy sector, boasting a market capitalization of $309.76 billion. Despite a recent slight dip in..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring Growth in the Medical Devices Sector

ClearPoint Neuro Inc. (CLPT), a pioneering name in the healthcare sector, is making waves with its innovative approach to minimally invasive brain surgery. Headquartered in Solana..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: A Compelling 270% Upside Potential in Biotech

Abeona Therapeutics Inc. (NASDAQ: ABEO), a cutting-edge player in the biotechnology sector, is capturing investor attention with its promising pipeline and remarkable upside potential. This Cleveland-based..

Phathom Pharmaceuticals (PHAT) Stock Analysis: Exploring Nearly 93% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a biopharmaceutical company specializing in gastrointestinal treatments, has caught the attention of the investment community due to its significant growth potential..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring the 300% Potential Upside

Investors are always on the lookout for opportunities that present significant potential returns, and aTyr Pharma, Inc. (NASDAQ: ATYR) is currently drawing attention with its staggering..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unraveling its 71.68% Potential Upside

CytomX Therapeutics, Inc. (NASDAQ: CTMX), a pioneering entity in the biotechnology landscape, is capturing the attention of investors with its innovative approach to cancer treatment. Specializing..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a Potential 91.66% Upside

XOMA Royalty Corporation (NASDAQ: XOMA), a key player in the biotechnology sector, is capturing investor interest with its unique business model and promising financial outlook. Headquartered..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Promising 33% Upside in Biotech Sector

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) stands out as a compelling player in the biotechnology sector, with a market capitalization of $515.88 million. Specializing in therapies that..

Exxon Mobil Corporation (XOM) Stock Analysis: Evaluating a 9.48% Potential Upside in the Energy Giant

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to capture investor attention with its substantial market capitalization of $486.1 billion. As a..

Mereo BioPharma Group plc (MREO) Investor Outlook: A Bold 260% Upside Potential Beckons

Mereo BioPharma Group plc (NASDAQ: MREO), a UK-based biotechnology firm, is capturing investor attention with its compelling 260.28% potential upside, according to recent analyst price targets...

MiMedx Group, Inc (MDXG) Stock Analysis: A 66.89% Potential Upside with Robust Growth Prospects

MiMedx Group, Inc. (NASDAQ: MDXG) is carving out a significant niche within the biotechnology sector, focusing on the innovative development and distribution of placental tissue allografts...

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 15% Potential Upside in the Biotech Sector

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has been gaining traction in the biotechnology sector, capturing investor interest with its robust market capitalization of $2.95 billion. As a..

Harrow, Inc. (HROW) Stock Analysis: Exploring the 61.71% Upside Potential

For investors seeking promising opportunities in the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents an intriguing prospect with an impressive potential upside of 61.71%. As a..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Potential Upside and Analyst Insights

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the healthcare sector, operates within the medical care facilities industry, providing crucial services to nursing homes,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 174% Potential Upside for Investors

Wave Life Sciences Ltd. (WVE), a clinical-stage biotechnology company based in Singapore, is capturing the attention of investors with its innovative RNA medicines platform, PRISM. As..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with 40.97% Potential Upside

Establishment Labs Holdings Inc (NASDAQ: ESTA), a pioneering medical technology company headquartered in Alajuela, Costa Rica, continues to capture investor interest in the healthcare sector. Specializing..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a Challenging Landscape with Growth Potential

Azenta, Inc. (NASDAQ: AZTA) stands as a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds